HiloProbe AB

https://www.hiloprobe.se

HiloProbe is a biotechnology company founded 2016. The founders consist of a group of scientists, who have collaborated for more than 15 years in an academic setting and have produced high quality original research focusing on the development of clinically useful biomarkers in colorectal cancer. The research has been focused on analysis of the regional lymph nodes in the resected specimen. The reason is that the lymph node is the first site where metastasizing cancer cells will occur. We have now discovered a limited number of biomarkers that, when analyzed together, identify tumor cells in the lymph node and grade tumor cell aggressiveness i.e. their propensity to metastasize to distant sites. A product (ColoNode®), based on biomarker mRNA analysis, has been developed. The aim is to bring ColoNode® to the market to save people´s lives and aid in the development of more efficient treatment of colorectal cancer. *

	Start	2017-09-13 existent
	Industry	molecular diagnostics
	Industry 2	personalised medicine / precision medicine
	Person	Olsson, Lina (HiloProbe 202305 CEO)

	Region	Umeå
	Country	Sweden
	Street	48 C Tvistevägen
	City	90736 Umeå
		Address record changed: 2023-05-21

Basic data	Employees	n. a.

		* Document for »About Section«: Biocartis Group N.V.. (5/9/23). "Press Release: Biocartis and HiloProbe to Collaborate on Colorectal Cancer Test". Mechelen.

		Record changed: 2024-02-12

Picture Berlin Partner Top News Healthtech Company Mika 650x200px

More documents for HiloProbe AB

[1] Biocartis Group N.V.. (5/9/23). "Press Release: Biocartis and HiloProbe to Collaborate on Colorectal Cancer Test". Mechelen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]